Large Market Deal of the Year: EQT and Aldevron
EQT sold Aldevron for $9.6bn just 22 months after buying the maker of mRNA vaccine components for $3.4bn.
EQT sold Aldevron for $9.6bn just 22 months after buying the maker of mRNA vaccine components for $3.4bn.
Copyright PEI Media
Not for publication, email or dissemination